Clinical trials
Terminated Lung Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
372 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 3 |
| 2002 | 5 |
| 2003 | 11 |
| 2004 | 13 |
| 2005 | 9 |
| 2006 | 29 |
| 2007 | 18 |
| 2008 | 21 |
| 2009 | 21 |
| 2010 | 21 |
| 2011 | 17 |
| 2012 | 16 |
| 2013 | 11 |
| 2014 | 10 |
| 2015 | 16 |
| 2016 | 12 |
| 2017 | 17 |
| 2018 | 15 |
| 2019 | 15 |
| 2020 | 14 |
| 2021 | 29 |
| 2022 | 16 |
| 2023 | 12 |
| 2024 | 8 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 372 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 21 |
| M.D. Anderson Cancer Center | 20 |
| Pfizer | 11 |
| Mayo Clinic | 10 |
| Massachusetts General Hospital | 7 |
| Vanderbilt-Ingram Cancer Center | 7 |
| Alliance for Clinical Trials in Oncology | 6 |
| SWOG Cancer Research Network | 6 |
| Stanford University | 6 |
| Indiana University | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 372 |
| Carcinoma, Non-Small-Cell Lung | 186 |
| Breast Neoplasms | 51 |
| Neoplasm Metastasis | 46 |
| Neoplasms | 46 |
| Small Cell Lung Carcinoma | 28 |
| Adenocarcinoma of Lung | 25 |
| Head and Neck Neoplasms | 24 |
| Prostatic Neoplasms | 24 |
| Melanoma | 23 |
Trials
Showing 1 to 25 of 372. Each trial links to its page on Pharma Observatory.
272 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.